Hepatic Stellate Cell-Immune Interactions in NASH.


Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2022
Historique:
received: 01 02 2022
accepted: 29 04 2022
entrez: 27 6 2022
pubmed: 28 6 2022
medline: 29 6 2022
Statut: epublish

Résumé

Nonalcoholic fatty liver disease (NAFLD) is the dominant cause of liver disease worldwide. Nonalcoholic steatohepatitis (NASH), a more aggressive presentation of NAFLD, is characterized by severe hepatocellular injury, inflammation, and fibrosis. Chronic inflammation and heightened immune cell activity have emerged as hallmark features of NASH and key drivers of fibrosis through the activation of hepatic stellate cells (HSCs). Recent advances in our understanding of the molecular and cellular pathways in NASH have highlighted extensive crosstalk between HSCs and hepatic immune populations that strongly influences disease activity. Here, we review these findings, emphasizing the roles of HSCs in liver immunity and inflammation, key cell-cell interactions, and exciting areas for future investigation.

Identifiants

pubmed: 35757404
doi: 10.3389/fendo.2022.867940
pmc: PMC9218059
doi:

Types de publication

Journal Article Review Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

867940

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK020541
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM062754
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK128289
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007280
Pays : United States

Informations de copyright

Copyright © 2022 Carter and Friedman.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Transplantation. 2008 Dec 15;86(11):1492-502
pubmed: 19077880
J Hepatol. 2020 Oct;73(4):757-770
pubmed: 32360434
iScience. 2020 Feb 21;23(2):100841
pubmed: 32058955
Immunity. 2019 Oct 15;51(4):638-654.e9
pubmed: 31561945
Cell Metab. 2017 May 2;25(5):1054-1062.e5
pubmed: 28467925
Hepatology. 2012 Jun;55(6):1976-84
pubmed: 22109893
Hepatology. 2021 Aug;74(2):667-685
pubmed: 33550587
Nat Rev Gastroenterol Hepatol. 2020 Aug;17(8):457-472
pubmed: 32483353
Cell. 2018 Nov 15;175(5):1289-1306.e20
pubmed: 30454647
J Hepatol. 2019 Mar;70(3):531-544
pubmed: 30414863
Front Immunol. 2021 Feb 08;11:616044
pubmed: 33628208
J Hepatol. 2017 Dec;67(6):1265-1273
pubmed: 28803953
J Clin Invest. 2019 Jul 11;129(10):4091-4109
pubmed: 31295147
Hepatology. 2013 Aug;58(2):589-602
pubmed: 23322710
Nature. 2021 Apr;592(7854):444-449
pubmed: 33762736
J Hepatol. 2017 May;66(5):1037-1046
pubmed: 28167322
J Clin Invest. 1993 Oct;92(4):1674-80
pubmed: 8408620
Gastroenterology. 2006 Feb;130(2):435-52
pubmed: 16472598
Semin Liver Dis. 2021 May;41(2):150-162
pubmed: 34107544
Am J Physiol Gastrointest Liver Physiol. 2007 Oct;293(4):G809-16
pubmed: 17673545
Hepatology. 2007 Nov;46(5):1509-18
pubmed: 17705260
Cell Rep. 2021 Jan 12;34(2):108626
pubmed: 33440159
Hepatology. 2021 Oct;74(4):2277-2286
pubmed: 33961302
Hepatology. 2021 Aug;74(2):704-722
pubmed: 33609303
J Hepatol. 2014 May;60(5):1055-62
pubmed: 24445215
Dig Dis Sci. 2016 May;61(5):1294-303
pubmed: 26841783
Hepatology. 2010 Nov;52(5):1769-82
pubmed: 21038415
Hepatology. 2009 May;49(5):1683-94
pubmed: 19205035
Front Endocrinol (Lausanne). 2021 Oct 28;12:760860
pubmed: 34777255
Hepatology. 2003 Oct;38(4):919-29
pubmed: 14512879
J Immunol. 2011 May 15;186(10):5549-55
pubmed: 21460203
Antioxid Redox Signal. 2015 Dec 1;23(16):1255-69
pubmed: 26058518
Gastroenterology. 2014 May;146(6):1513-24
pubmed: 24440671
Cytokine. 2019 Dec;124:154542
pubmed: 30241896
Front Immunol. 2021 Jun 15;12:691073
pubmed: 34211477
Gut. 2017 Jun;66(6):1123-1137
pubmed: 26818617
Cell. 2021 May 13;184(10):2537-2564
pubmed: 33989548
Hepatology. 2009 Jun;49(6):2055-67
pubmed: 19434726
Front Immunol. 2019 Sep 11;10:2180
pubmed: 31572388
Nat Rev Gastroenterol Hepatol. 2018 Jun;15(6):349-364
pubmed: 29740166
Diabetes. 2010 Feb;59(2):347-57
pubmed: 19934001
J Clin Invest. 2019 Feb 1;129(2):546-555
pubmed: 30561388
Hepatology. 2015 Jun;61(6):2067-79
pubmed: 25711908
Mol Ther Methods Clin Dev. 2016 Dec 24;4:50-61
pubmed: 28344991
Nat Cell Biol. 2020 Jun;22(6):728-739
pubmed: 32367049
Curr Opin Gastroenterol. 2017 May;33(3):128-133
pubmed: 28257306
J Immunol. 2001 Jun 1;166(11):6812-9
pubmed: 11359840
Gut. 2012 Sep;61(9):1323-9
pubmed: 22427237
Immunity. 2007 Jan;26(1):117-29
pubmed: 17239632
Physiol Rev. 2008 Jan;88(1):125-72
pubmed: 18195085
J Mol Med (Berl). 2016 Oct;94(10):1143-1151
pubmed: 27271256
Nat Commun. 2018 Jun 1;9(1):2146
pubmed: 29858567
Lab Invest. 2005 Nov;85(11):1368-80
pubmed: 16170335
Hepatol Commun. 2020 Jul 29;4(10):1441-1458
pubmed: 33024915
J Clin Invest. 2019 Mar 11;129(4):1684-1698
pubmed: 30855276
Hepatology. 2018 Jul;68(1):172-186
pubmed: 29328499
Hepatology. 2008 Feb;47(2):729-36
pubmed: 18167066
Cell Metab. 2019 Feb 5;29(2):383-398.e7
pubmed: 30449686
J Immunol. 2016 Feb 15;196(4):1617-25
pubmed: 26755818
Hepatology. 2016 Apr;63(4):1325-39
pubmed: 26248612
Nature. 2019 Nov;575(7783):512-518
pubmed: 31597160
Clin Transl Gastroenterol. 2020 Mar;11(3):e00131
pubmed: 32352707
PLoS One. 2013 Dec 11;8(12):e82163
pubmed: 24349208
Hepatology. 2010 Feb;51(2):511-22
pubmed: 20054868
J Hepatol. 2018 Feb;68(2):238-250
pubmed: 29154966
Cancer Cell. 2014 Oct 13;26(4):549-64
pubmed: 25314080
Gastroenterology. 2018 Dec;155(6):1971-1984.e4
pubmed: 30213555
Nat Commun. 2021 Jul 22;12(1):4474
pubmed: 34294714
J Hepatol. 2018 Apr;68(4):643-645
pubmed: 29408544
Hepatology. 2013 Jan;57(1):339-50
pubmed: 22961591
Nat Rev Gastroenterol Hepatol. 2017 Jul;14(7):397-411
pubmed: 28487545
Nat Commun. 2019 Mar 29;10(1):1406
pubmed: 30926798
Gastroenterology. 2020 May;158(7):1913-1928
pubmed: 32044315
Hepatology. 2014 Dec;60(6):2027-39
pubmed: 25351459
Hepatology. 2011 Mar;53(3):1007-19
pubmed: 21374665
Hepatol Commun. 2018 Feb 14;2(3):285-298
pubmed: 29507903
Cell Mol Gastroenterol Hepatol. 2018 Jan 08;5(3):399-413
pubmed: 29552626
Free Radic Biol Med. 2018 Aug 20;124:249-259
pubmed: 29920340
Hepatology. 2006 Nov;44(5):1171-81
pubmed: 17058227
Gastroenterology. 2015 Mar;148(3):547-55
pubmed: 25461851
Nature. 2020 Jul;583(7814):127-132
pubmed: 32555459
Nat Rev Immunol. 2022 Jul;22(7):429-443
pubmed: 34741169
J Hepatol. 2020 Nov;73(5):1219-1230
pubmed: 32534107
Gut. 2012 Mar;61(3):416-26
pubmed: 21813474
FASEB J. 2013 Jul;27(7):2573-83
pubmed: 23504711
Hepatology. 2014 Feb;59(2):630-42
pubmed: 23959575
Hepatology. 2009 Mar;49(3):960-8
pubmed: 19085953
Cell Metab. 2020 Feb 4;31(2):406-421.e7
pubmed: 31839486
J Hepatol. 2007 Feb;46(2):295-303
pubmed: 17125875
Front Endocrinol (Lausanne). 2021 Oct 11;12:751802
pubmed: 34707573
PLoS One. 2021 Jan 4;16(1):e0244763
pubmed: 33395434
Nat Metab. 2019 Jun;1(6):604-614
pubmed: 31701087
Gastroenterology. 2004 Sep;127(3):870-82
pubmed: 15362042
Nat Rev Genet. 2021 Feb;22(2):71-88
pubmed: 33168968
Nat Rev Gastroenterol Hepatol. 2019 Mar;16(3):145-159
pubmed: 30482910
J Clin Immunol. 2011 Dec;31(6):1120-30
pubmed: 21845516
PLoS One. 2014 Jan 08;9(1):e83391
pubmed: 24416163
Am J Physiol Gastrointest Liver Physiol. 2009 Dec;297(6):G1093-106
pubmed: 19815628
J Immunol. 2012 Oct 15;189(8):3848-58
pubmed: 22962681
Semin Liver Dis. 2001 Aug;21(3):417-26
pubmed: 11586469
Nat Med. 2007 Nov;13(11):1324-32
pubmed: 17952090
Proc Natl Acad Sci U S A. 2012 Nov 13;109(46):E3186-95
pubmed: 23100531
J Hepatol. 2020 Nov;73(5):1013-1022
pubmed: 32540177
Hepatobiliary Surg Nutr. 2014 Dec;3(6):344-63
pubmed: 25568859
Hepatol Res. 2013 Jun;43(6):658-69
pubmed: 23107150
Hepatology. 2019 Feb;69(2):845-859
pubmed: 30180270
Am J Physiol Gastrointest Liver Physiol. 2003 Nov;285(5):G949-58
pubmed: 12829440
Gastroenterology. 2014 Oct;147(4):754-64
pubmed: 25109884
Am J Physiol Gastrointest Liver Physiol. 2013 Dec;305(12):G891-9
pubmed: 24136786
J Immunol. 2013 Mar 1;190(5):2009-16
pubmed: 23359509
J Immunol. 2018 Nov 15;201(10):3017-3035
pubmed: 30322964
Front Immunol. 2021 Feb 18;12:640869
pubmed: 33679803
J Hepatol. 2018 Sep;69(3):654-665
pubmed: 29758330
Hepatol Int. 2013 Jun;7(2):539-47
pubmed: 26201785
Hepatology. 2016 Dec;64(6):2219-2233
pubmed: 27628960
Cell. 2018 Feb 8;172(4):744-757.e17
pubmed: 29398113
Hepatology. 2010 Oct;52(4):1390-400
pubmed: 20683935
Transplantation. 2013 Jul 15;96(1):17-24
pubmed: 23756770
Cell Metab. 2019 Oct 1;30(4):675-688.e7
pubmed: 31543403
Immunity. 2020 Sep 15;53(3):641-657.e14
pubmed: 32888418
Mol Cell. 2019 Aug 8;75(3):644-660.e5
pubmed: 31398325
Front Immunol. 2019 Mar 15;10:477
pubmed: 30930903
J Hepatol. 2021 Jan;74(1):156-167
pubmed: 32763266
Hepatol Commun. 2017 Jun;1(4):299-310
pubmed: 29152605
Sci Immunol. 2017 Apr 21;2(10):
pubmed: 28567448
Sci Rep. 2021 Sep 29;11(1):19396
pubmed: 34588551
Hepatology. 2011 Jun;53(6):2003-15
pubmed: 21433043
J Hepatol. 2020 Aug;73(2):394-408
pubmed: 32298766
Gut. 2012 Jun;61(6):885-93
pubmed: 22198715
Nat Med. 2021 Jun;27(6):1043-1054
pubmed: 34017133
Hepatology. 2003 May;37(5):1043-55
pubmed: 12717385
Immunity. 2020 Sep 15;53(3):627-640.e5
pubmed: 32562600
Hepatology. 2018 Apr;67(4):1270-1283
pubmed: 28940700
J Hepatol. 2019 Dec;71(6):1216-1228
pubmed: 31419514
Semin Liver Dis. 2020 Aug;40(3):307-320
pubmed: 32242330
Nat Rev Gastroenterol Hepatol. 2020 Feb;17(2):81-92
pubmed: 31605031
Nat Rev Immunol. 2004 Aug;4(8):583-94
pubmed: 15286725
J Clin Invest. 2021 Feb 15;131(4):
pubmed: 33586673
Nat Protoc. 2020 Apr;15(4):1484-1506
pubmed: 32103204
Liver Res. 2018 Mar;2(1):43-51
pubmed: 30416839
J Hepatol. 2006 Jul;45(1):60-71
pubmed: 16515819
Cell Mol Immunol. 2016 May;13(3):277-92
pubmed: 27041638
Gut. 2015 May;64(5):830-41
pubmed: 25681399
Nat Rev Immunol. 2017 May;17(5):306-321
pubmed: 28317925
J Dig Dis. 2016 Jul;17(7):464-74
pubmed: 27216040
Hepatology. 2011 Jul;54(1):262-72
pubmed: 21488077
Hepatology. 2004 Dec;40(6):1312-21
pubmed: 15565659
JCI Insight. 2017 Nov 16;2(22):
pubmed: 29202448
Hepatology. 1996 Sep;24(3):670-6
pubmed: 8781341
Hepatology. 1992 Sep;16(3):776-84
pubmed: 1505921

Auteurs

James K Carter (JK)

Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Medical Scientist Training Program, Icahn School of Medicine at Mount Sinai, New York, NY, United States.

Scott L Friedman (SL)

Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH